These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 26446044)

  • 1. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
    Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
    Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
    Trujillo-Estrada L; Jimenez S; De Castro V; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; Navarro V; Sanchez-Varo R; Sanchez-Mejias E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Acta Neuropathol Commun; 2013 Nov; 1():73. PubMed ID: 24252759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine improves behavioral performance by suppressing the production of soluble β-amyloid in APP/PS1 mice.
    Wang J; Zhang Y; Xu H; Zhu S; Wang H; He J; Zhang H; Guo H; Kong J; Huang Q; Li XM
    Curr Alzheimer Res; 2014; 11(7):672-80. PubMed ID: 25115542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.
    Ma J; Gao Y; Jiang L; Chao FL; Huang W; Zhou CN; Tang W; Zhang L; Huang CX; Zhang Y; Luo YM; Xiao Q; Yu HR; Jiang R; Tang Y
    Oncotarget; 2017 Apr; 8(17):27676-27692. PubMed ID: 28430602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
    Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
    Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
    Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
    BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M; Edelmann E; Leßmann V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Nov; 86():241-58. PubMed ID: 25107586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
    Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
    Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology.
    Zhang Q; Yang C; Liu T; Liu L; Li F; Cai Y; Lv K; Li X; Gao J; Sun D; Xu H; Yang Q; Fan X
    Neuropharmacology; 2018 Mar; 131():475-486. PubMed ID: 29241655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer's Disease Mice.
    Ma J; Gao Y; Tang W; Huang W; Tang Y
    Curr Alzheimer Res; 2020; 17(1):93-103. PubMed ID: 32053075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
    Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
    Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.